MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Store in airtight containers.

Provenance

This compatibility recommendation is derived from Monosorb XL 60 tablets (Dexcel-Pharma Ltd), Isotard 60XL tablets (Kyowa Kirin Ltd) and Monomax XL 60mg tablets (Chiesi Ltd).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

Compatability information derived from Medrone 100mg tablets (Pfizer Ltd).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

Compatability information derived from Medrone 100mg tablets (Pfizer Ltd).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

Compatability information derived from Medrone 100mg tablets (Pfizer Ltd).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

Compatiblity information dervied from Medrone 16mg tablets (Pfizer Ltd)

Stability Notes

Protect from light. Store in airtight containers.

Provenance

Compatibility information derived from Medrone 2mg tablets (Pfizer Ltd).

Stability Notes

Protect from light. Store in airtight containers.

Provenance

Compatiblity information derived from Medrone 4mg tablets (Pfizer Ltd)

Stability Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Provera 100mg tablets (Pfizer Ltd).

Stability Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Provera 10mg tablets (Pfizer Ltd).

Stability Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Provera 2.5mg tablets (Pfizer Ltd).

Stability Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Provera 200mg tablets (Pfizer Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.